Study to improve HIV prevention habits in young gay and bisexual men
Part of Infections clinical trials.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 34 years old.
- You are HIV-negative (confirmed by a quick test).
- You identify as gay or bisexual.
- You have used methamphetamine in the past 3 months.
- You are currently prescribed and taking PrEP medication to prevent HIV.
- You have missed some doses of PrEP in the past 3 months and have had condomless anal sex or a sexually transmitted infection in that time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to help Black men who have sex with men stay on PrEP (HIV prevention pills) over time. If you are at risk for HIV and have stopped taking PrEP for at least a month, you may be able to join and get support to keep taking it.
This study tests ways to help Latino men who have sex with men use PrEP, a medicine that helps prevent HIV. You may be invited if you are HIV-negative (or your status is unknown), are not currently on PrEP, and can read and write Spanish.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
This trial tests ways to improve how well people take PrEP (a medicine that helps prevent HIV) consistently. It may help you if you’re at higher risk and are not currently on PrEP, especially around starting and staying on it.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests a '2-1-1' on-demand PrEP strategy for cisgender men who have sex with men. It aims to see if taking PrEP only around the time of sex is safe and effective. If you are interested in starting or currently taking PrEP this way, you may be eligible.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.